Send Inquiry

Request To Call Back

Veenat Capsules

Name: Veenat Capsules
Brand: HEET HEALTHCARE PVT. LTD.

Get a Price/Quote

MOQ : 1 Box

Veenat Capsules Specification

Dosage Form
Capsule

Origin
India

Enzyme Types
Veenat Capsules

Fermentation Smell
Normal Smell

Storage Instructions
Dry & Cool Place

Shelf Life
1 Years

Veenat Capsules Trade Information

Minimum Order Quantity
1 Box

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

Main Export Market(s)
Australia, South America, Eastern Europe, Middle East, Western Europe, Africa, Asia, Central America, North America

Main Domestic Market
All India

About Veenat Capsules

Imatinib, a tyrosine kinase inhibitor used to treat specific cancers, is the active component of Veenat capsules. It is typically recommended for gastrointestinal stromal tumours (GISTs) and chronic myeloid leukaemia (CML). Imatinib functions by preventing particular proteins from promoting the proliferation and development of cancer cells. Veenat promotes remission, slows the spread of cancer, and raises overall survival rates. The kind and stage of the cancer, as well as the patient's reaction to treatment, determine the dosage and length of the course of treatment. In order to control any side effects and guarantee the best treatment results, routine medical monitoring is essential.

Features and Advantages of Veenat (Imatinib) Capsules:

Features:

1. Tyrosine kinase inhibitor imatinib, the active component of Veenat capsules, is a tyrosine kinase inhibitor.

2. Veenat is generally given for the treatment of gastrointestinal stromal tumours (GISTs) and chronic myeloid leukaemia (CML).

3. Tyrosine Kinase Inhibition: Imatinib inhibits certain proteins known as tyrosine kinases that are essential for the growth and division of cancer cells.

4. Veenat provides tailored therapy that specifically targets cancer cells while sparing healthy cells.

5. Veenat is administered orally in the form of capsules, making it convenient for patients to give at home.

6. Personalised Treatment: Veenat enables a personalised treatment strategy depending on the particulars of the patient and the features of the cancer.

Benefits:

1. Veenat is a key component in the management of chronic myeloid leukaemia (CML), which improves patient outcomes and prolongs the duration of disease control.

2. Remission induction: Veenat aids in the process of remission, in which the quantity or visibility of cancer cells declines.

3. Prolonged Survival: Veenat has been demonstrated to increase patients' chances of long-term survival in cases of CML and GIST.

4. Slower Cancer Progression: Veenat reduces the growth and multiplication of cancer cells by blocking tyrosine kinases.

5. Better Tolerance: Compared to traditional chemotherapy, Veenat is often well-tolerated and has tolerable side effects.

6. Veenat capsules can frequently be administered as an outpatient procedure, eliminating the requirement for protracted hospital stays.

7. Research is still being conducted, and this is giving patients more alternatives for treatment by examining new combinations and uses of imatinib.

Before beginning Veenat (Imatinib) capsule therapy, patients must discuss potential side effects and advantages with their doctor. To manage potential side effects and achieve the greatest results, regular medical monitoring is essential. Veenat use requires knowledge, and treatment decisions should be made in collaboration between patients and their oncologists while taking into account unique circumstances and therapeutic objectives. To manage side effects and maximise therapy efficacy, patients should be regularly watched and given supportive care.

Veenat Capsules (Imatinib) Uses:

The following conditions are treated using Veenat capsules, which contain the active component imatinib:

1. Veenat is recommended for the treatment of chronic myeloid leukaemia (CML), as well as for the treatment of CML in the accelerated phase, blast crisis, or following the failure of interferon-alpha therapy.

2. Gastrointestinal Stromal Tumours (GISTs): Veenat is indicated as adjuvant therapy following complete resection of GISTs for the treatment of unresectable and/or metastatic GISTs.

Veenat Capsules (Imatinib) Side Effects

Veenat is generally well accepted, although some people may experience some adverse effects. Typical negative consequences could be:

Nausea and Vomiting
Diarrhea or Constipation
Muscle Cramps
Fluid Retention or Edema
Fatigue or Weakness
Skin Rash or Itching
Headache
Joint Pain
Abdominal Pain
Low Blood Counts (Anemia, Neutropenia, Thrombocytopenia)
Liver Function Test Abnormalities
Elevated Blood Glucose Levels (Hyperglycemia)
Heart Problems (e.g., Edema, Heart Failure)

During the course of their Veenat capsules treatment, patients must immediately notify their healthcare practitioner of any worrying symptoms or side effects. To manage potential adverse effects and maximise therapy effectiveness, routine blood tests and medical monitoring are required. Veenat use requires knowledge, and treatment decisions should be made in collaboration between patients and their oncologists while taking into account unique circumstances and therapeutic objectives. To manage side effects and guarantee the best treatment outcomes, patients should be regularly watched and given supportive care.

Product Highlights

Veenat Capsules distinguish themselves by their reliable quality, Indian origin, and adherence to pharmaceutical standards. Manufactured under strict conditions, these capsules offer therapeutic benefits when used as prescribed. Their ordinary fermentation smell is typical for this formulation.

Proper Storage to Ensure Efficacy

To maintain the effectiveness and shelf life of Veenat Capsules, it is essential to store them in a dry, cool place. Exposure to moisture or high temperatures can affect the capsules' stability and reduce their medicinal value. Follow storage guidelines for optimal results.

FAQ's of Veenat Capsules:

Q: How should Veenat Capsules be stored for maximum effectiveness?

A: Veenat Capsules should be kept in a cool, dry place, away from direct sunlight and moisture. Proper storage helps preserve their quality and therapeutic potential throughout the one-year shelf life.

Q: What is the shelf life of Veenat Capsules and how can I ensure they remain effective?

A: These capsules have a shelf life of one year. To ensure their potency, store them in the recommended dry and cool environment, and keep the packaging tightly closed when not in use.

Q: Where are Veenat Capsules manufactured and distributed?

A: Veenat Capsules are manufactured in India and distributed locally and internationally by various suppliers, exporters, importers, and traders based in India.

Q: When is the best time to use Veenat Capsules?

A: The best time to use Veenat Capsules is as prescribed by your healthcare professional. Follow the dosage schedule provided for optimal therapeutic benefits.

Q: What is the typical smell of Veenat Capsules, and is it normal?

A: Veenat Capsules possess a natural fermentation smell, which is normal for this type of medication and does not indicate spoilage or reduced efficacy.

Q: How do I benefit from using Veenat Capsules?

A: When taken as directed, Veenat Capsules provide their intended therapeutic benefits, helping to manage the medical condition for which they were prescribed. Always consult with your healthcare provider for optimal results.

Tell us about your requirement